Technical Analysis for CSL - CSL Limited
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| D | 288.610 | 0.55% | 1.590 |
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Flat | Down | Flat |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Crossed Above 200 DMA | Bullish | 0.00% | |
| NR7 | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Oversold Stochastic | Weakness | 0.00% | |
| Fell Below 200 DMA | Bearish | 0.55% | |
| New Downtrend | Bearish | 0.55% | |
| Inside Day | Range Contraction | 0.55% | |
| Gapped Down | Weakness | 0.55% | |
| Oversold Stochastic | Weakness | 0.55% | |
| New Downtrend | Bearish | 0.14% |
| Alert | Time |
|---|---|
| 200 DMA Support | about 12 hours ago |
| Possible NR7 | about 13 hours ago |
| 200 DMA Resistance | about 16 hours ago |
| 10 DMA Resistance | about 16 hours ago |
| Gapped Up (Full) | about 17 hours ago |
Get this analysis on your stocks daily!
CSL Limited Description
CSL Limited is a biotherapeutics company that develops and delivers biotherapies. The Company's principal activities are research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. Its segments include CSL Behring, Seqirus and CSL Intellectual Property. The CSL Behring segment manufactures, markets and develops plasma therapies (plasma products and recombinants). The Seqirus segment manufactures and distributes non-plasma biotherapeutic products. Seqirus manufactures, sells and distributes a range of vaccines, antivenoms and other pharmaceutical products in Australia and New Zealand. It also manufactures and markets in vitro diagnostic products through Seqirus immunohematology. The CSL Intellectual Property segment is engaged in licensing of intellectual property generated by the Company to unrelated third parties. The Company has facilities in Australia, Germany, Switzerland, the United Kingdom and the United States.
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Health Marketing Pharmaceutical Biotechnology Intellectual Property Biopharmaceutical Therapeutic Product Therapeutic Products In Vitro Pharmaceutical Products Pharmacology Diagnostic Products
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 311.2911 |
| 52 Week Low | 225.6191 |
| Average Volume | 655,109 |
| 200-Day Moving Average | 288.291 |
| 50-Day Moving Average | 300.186 |
| 20-Day Moving Average | 293.745 |
| 10-Day Moving Average | 288.681 |
| Average True Range | 3.842 |
| RSI (14) | 38.65 |
| ADX | 24.86 |
| +DI | 18.948 |
| -DI | 28.679 |
| Chandelier Exit (Long, 3 ATRs) | 292.003 |
| Chandelier Exit (Short, 3 ATRs) | 295.377 |
| Upper Bollinger Bands | 305.107 |
| Lower Bollinger Band | 282.382 |
| Percent B (%b) | 0.27 |
| BandWidth | 7.737 |
| MACD Line | -4.001 |
| MACD Signal Line | -3.570 |
| MACD Histogram | -0.4305 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 292.315 | ||||
| Resistance 3 (R3) | 292.200 | 290.850 | 291.698 | ||
| Resistance 2 (R2) | 290.850 | 289.906 | 290.908 | 291.492 | |
| Resistance 1 (R1) | 289.730 | 289.324 | 289.055 | 289.845 | 291.286 |
| Pivot Point | 288.380 | 288.380 | 288.043 | 288.438 | 288.380 |
| Support 1 (S1) | 287.260 | 287.436 | 286.585 | 287.375 | 285.934 |
| Support 2 (S2) | 285.910 | 286.854 | 285.968 | 285.728 | |
| Support 3 (S3) | 284.790 | 285.910 | 285.523 | ||
| Support 4 (S4) | 284.905 |
